Boston Partners has increased its stake in NXP Semiconductors N.V. by 16.7%, acquiring an additional 406,278 shares, bringing their total ownership to 2,845,867 shares valued at $621.16 million. Other institutional investors like UBS AM and Van Lanschot Kempen Investment Management N.V. also boosted their holdings. Wall Street analysts maintain a "Moderate Buy" rating for NXPI, with an average target price of $295.92, despite recent insider share sales.

Atalanta Sosnoff Capital LLC reduced its stake in United Rentals, Inc. by 16.6% in the fourth quarter, selling 7,897 shares and retaining 39,546 shares valued at $32,006,000. Despite this reduction by one firm, several other institutional investors increased their holdings in United Rentals during recent quarters. The article also notes recent insider stock sales, the company's financial performance including a missed earnings estimate, and analyst ratings which generally recommend a "Moderate Buy" for URI.

Gerber Kawasaki Wealth & Investment Management has reduced its stake in The Home Depot, Inc. by 10.1% in the fourth quarter, selling 3,789 shares and now holding 33,775 shares valued at $11.6 million. Despite this sale, Home Depot reported strong Q4 earnings with an EPS of $3.43 and revenue of $41.77 billion, exceeding analyst expectations. The company also declared a quarterly dividend of $2.33 per share and holds a "Moderate Buy" consensus rating from analysts with a price target of $371.36.

Columbia Bank has lowered its holdings in Apple Inc. by 6.1% in the fourth quarter, selling 3,848 shares, though Apple remains its fifth-largest position. Insider selling also continued with two executives divesting shares. Despite these reductions, Apple's fundamentals and analyst sentiment are largely positive, marked by strong earnings, a dividend increase, and a "Moderate Buy" consensus rating, although some investors are hesitant waiting for stronger evidence that AI updates will significantly boost growth.

Boston Partners has reduced its stake in Allegion PLC by 2.8% in the fourth quarter, now holding 4.61 million shares valued at $734.7 million. Despite significant institutional ownership (92.21%) and a recent share repurchase program announcement, analysts maintain a "Hold" rating with an average price target of $160.89, partly due to the company missing quarterly EPS expectations. Insider selling by SVP Robert C. Martens was also noted, reducing his ownership by over 31%.

Howland Capital Management LLC significantly increased its stake in NVIDIA Corporation (NVDA) by 8.3% in the fourth quarter, bringing its total holding to 533,121 shares valued at $99.43 million. This move comes as NVIDIA reported strong quarterly results, exceeding revenue and EPS expectations, and announced a substantial capital-return plan including a new dividend and an $80 billion share repurchase authorization. Analysts largely maintain a "Buy" rating for NVIDIA, with a consensus target price of $305.67.

Howland Capital Management LLC increased its stake in Cisco Systems by 32.6% during the fourth quarter, purchasing an additional 11,765 shares and bringing its total holdings to 47,822 shares valued at $3.68 million. Several analysts have raised their price targets for Cisco, contributing to a consensus "Moderate Buy" rating with an average target price of $120.64. The company recently reported strong quarterly earnings of $1.06 per share on revenues of $15.84 billion and announced a quarterly dividend of $0.42 per share.

Boston Partners has reduced its stake in Microchip Technology Incorporated ($MCHP) by 6.3% in the fourth quarter, selling over 1 million shares. Despite this reduction, Microchip Technology remains a significant part of Boston Partners' portfolio, accounting for 1.0% of their investments. Other institutional investors have increased their holdings, and analysts generally rate the stock as a "Moderate Buy."

GE HealthCare (GEHC) stock is drawing attention after a recent pullback, with market participants reassessing its long-term business outlook. The company specializes in imaging, ultrasound, patient monitoring, and healthcare technology services, placing it firmly in the healthcare stock category. Valuation signals suggest the market may be applying a cautious view to the stock despite ongoing demand for medical equipment and hospital technology.

Boston Partners has acquired 1.91 million shares of Labcorp Holdings Inc. (NYSE:LH), valued at approximately $480.3 million, giving them a 2.31% stake in the company. Labcorp recently reported strong quarterly results with $4.25 EPS and $3.54 billion in revenue, exceeding analyst expectations, and declared a quarterly dividend of $0.72 per share. Analyst sentiment remains largely positive with a "Moderate Buy" rating and a consensus target price of $308.00, despite some recent insider selling.